SOX9
protein-codingSRY-box transcription factor 9, the group of SRY-box transcription factors
Gene summary
The protein encoded by this gene recognizes the sequence CCTTGAG along with other members of the HMG-box class DNA-binding proteins. It acts during chondrocyte differentiation and, with steroidogenic factor 1, regulates transcription of the anti-Muellerian hormone (AMH) gene. Deficiencies lead to the skeletal malformation syndrome campomelic dysplasia, frequently with sex reversal. [provided by RefSeq, Jul 2008]
- CMD1
- CMPD1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~5.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0007251
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0009869
Submitter: ClinGen
Pierre Robin Sequence (PRS), a collection of clinical features consisting of mandibular hypoplasia, cleft secondary palate, and glossoptosis leading to obstructive apnea and feeding difficulties, was first described in 1923 by P. Robin. (PMIDs: 8171154, 23799581). PRS can present in isolation as well as in association with various conditions such as Stickler syndrome. Evidence supporting the SOX9-Pierre Robin Sequence gene disease relationship includes segregation data and experimental evidence including a mouse model. Deletions in the non-coding region of SOX9 have been identified in patients with PRS (PMIDs: 19234473, 23532965, 24934569). These variants have been found to cause reduced expression of SOX9 and KCNJ2 (PMIDs: 19234473, 17551083). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the Skeletal Disorders Gene Curation Expert Panel on 8/3/2020.
Inheritance Pattern: AD
Disease ID:MONDO:0007251
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0007134
Submitter: ClinGen
Cooks syndrome was first described in 1985 by Cooks et al. (PMID: 3978841). It was later associated with SOX9 (PMIDs: 19639023, 27706140, 31358994, 32470376). Evidence supporting this gene disease relationship includes segregation data and expression data. Large duplications at the 17q24.3 locus involving the coding regions of KCNJ2 and KCNJ16 as well as the regulatory region of SOX9 have been reported in patients with Cooks syndrome (PMIDs: 32583964, 32470376, 19639023). The mechanism of disease is thought to be misexpression of Kcnj2 due to a position effect which places the gene under the regulation of a SOX9 enhancer (PMID: 27706140, 32470376). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the Skeletal Disorders Gene Curation Expert Panel on 8/3/2020.
Inheritance Pattern: AD
Disease ID:MONDO:0007251
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0009869
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0007251
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0016281
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0010765
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0010766
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0009869
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007251
Submitter: ClinGen
SOX9 was reported in relations to autosomal dominant Campomelic dysplasia as early as 1994 (Foster et al. PMID: 7990924). This curation includes probands with Campomelic dysplasia, Acampomelic dysplasia, and Campomelic dysplasia with sex reversal. At least 6 unique variants (missense, nonsense, frameshift etc) have been reported in humans. Case-level and experimental data, including a mouse model, support this gene-disease relationship. More evidence is available in the literature, but the maximum score for genetic evidence has been reached. In summary, SOX9 is definitively associated with autosomal dominant Campomelic dysplasia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
Inheritance Pattern: AD
Disease ID:MONDO:0016674
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Oncologic; Renal; Genitourinary
Intervention: Cardiovascular; Oncologic
Rationale: Individuals with a 46,XY karyotype and genital undermasculinization may have an increased risk of gonadoblastoma, and gonadal removal has been recommended; The conditions can involve congenital cardiac anomalies, and awareness may allow early management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SOX9 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000346.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 106 | 4 | 113 | ||
| missense | 19 | 35 | 180 | 30 | 12 | 276 |
| nonsense | 23 | 10 | 3 | 36 | ||
| start loss | 0 | |||||
| frameshift | 33 | 26 | 5 | 64 | ||
| splice donor/acceptor (+/-2bp) | 7 | 1 | 8 | |||
| Total | 82 | 71 | 192 | 136 | 16 | 497 |
Highest pathogenic variant AF is 0.0000015041937
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000337.1 | 3 | MANE Select | |
| Ensembl | ENSP00000245479.2 | 3 | MANE Select | |
| Ensembl | ENSP00000547618.1 | 3 | Standard | |
| Ensembl | ENSP00000547618.1 | 3 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| sox9b | Danio rerio | Structure: iridophore Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- cAMP signaling pathway - Homo sapiens (human)
- Neural Crest Differentiation
- Spinal Cord Injury
- Endochondral Ossification
- Prostaglandin Synthesis and Regulation
Biological Process
- skeletal system development
- cartilage condensation
- ossification
- branching involved in ureteric bud morphogenesis
- cell fate specification
Molecular Function
- RNA polymerase II proximal promoter sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- enhancer sequence-specific DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- chromatin binding
Cellular Component
- nucleus
- nucleoplasm
- protein-containing complex
- nuclear transcription factor complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000245479
- Coding exons
- 3
- Length
- 5401
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.63 | 230 | 311 | 0.740 | 0.0000171 | 3299 |
| Missense (PolyPhen) | 52 | 101.25 | 0.51356 | 1035 | ||
| Synonymous | -2.26 | 182 | 147 | 1.24 | 0.00000974 | 1012 |
| Loss of Function | 3.91 | 0 | 17.8 | 0.00 | 8.62e-7 | 181 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcriptional regulator that plays a role in chondrocytes differentiation and skeletal development (PubMed:24038782). Binds to the COL2A1 promoter and activates COL2A1 expression, as part of a complex with ZNF219 (By similarity). {ECO:0000250|UniProtKB:Q04887, ECO:0000269|PubMed:24038782}.;
- Disease
- DISEASE: Campomelic dysplasia (CMD1) [MIM:114290]: A rare, often lethal, osteochondrodysplasia characterized by congenital bowing and angulation of long bones. Other skeletal defects include unusually small scapula, deformed pelvis and spine, and a missing pair of ribs. Craniofacial and ear defects are common. Most patients die soon after birth due to respiratory distress which has been attributed to hypoplasia of the tracheobronchial cartilage and small thoracic cage. Up to two-thirds of affected XY individuals have genital defects or may develop as phenotypic females. {ECO:0000269|PubMed:10446171, ECO:0000269|PubMed:10951468, ECO:0000269|PubMed:11323423, ECO:0000269|PubMed:11754051, ECO:0000269|PubMed:12783851, ECO:0000269|PubMed:19033726, ECO:0000269|PubMed:19921652, ECO:0000269|PubMed:20513132, ECO:0000269|PubMed:24038782, ECO:0000269|PubMed:7485151, ECO:0000269|PubMed:9002675, ECO:0000269|PubMed:9452059}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: 46,XX sex reversal 2 (SRXX2) [MIM:278850]: A condition in which male gonads develop in a genetic female (female to male sex reversal). {ECO:0000269|PubMed:21208124}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: 46,XY sex reversal 10 (SRXY10) [MIM:616425]: A disorder of sex development. Affected individuals have a 46,XY karyotype, show gonadal dysgenesis with streak gonads, look like normal females at birth, do not develop secondary sexual characteristics at puberty and do not menstruate. {ECO:0000269|PubMed:25604083}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.836
Intolerance Scores
- RVIS EVS
- -0.71
- RVIS percentile EVS
- 14.4
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.982
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |